Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris.

[1]  C. Selmi,et al.  Criteria for environmentally associated autoimmune diseases. , 2012, Journal of autoimmunity.

[2]  Q. Lu,et al.  Heritability versus the role of the environment in autoimmunity. , 2012, Journal of autoimmunity.

[3]  C. Selmi,et al.  Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. , 2012, Journal of autoimmunity.

[4]  Alan Menter,et al.  A subset of methylated CpG sites differentiate psoriatic from normal skin , 2011, The Journal of investigative dermatology.

[5]  Jun Wang,et al.  Whole genome DNA methylation analysis based on high throughput sequencing technology. , 2010, Methods.

[6]  Q. Lu,et al.  Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. , 2010, Journal of dermatological science.

[7]  Allen D. Delaney,et al.  Conserved Role of Intragenic DNA Methylation in Regulating Alternative Promoters , 2010, Nature.

[8]  Wan-long Tan,et al.  Reduced expression of programmed cell death 5 protein in tissue of human prostate cancer. , 2009, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[9]  Yan A. Su,et al.  Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy , 2009, Molecular Cancer Therapeutics.

[10]  Hanlee P. Ji,et al.  Next-generation DNA sequencing , 2008, Nature Biotechnology.

[11]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[12]  E. Mardis.  Next-generation DNA sequencing methods. , 2008, Annual review of genomics and human genetics.

[13]  J. Gong,et al.  The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance , 2008, The British journal of dermatology.

[14]  Yan-rong Liu,et al.  Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo , 2008, Apoptosis.

[15]  Ying Jiang,et al.  [PDCD5 induces the apoptosis of human prostate cancer cells PC-3M-1E8]. , 2007, Zhonghua nan ke xue = National journal of andrology.

[16]  E. Lander,et al.  The Mammalian Epigenome , 2007, Cell.

[17]  Ugo Pastorino,et al.  Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Gaspari.  Innate and adaptive immunity and the pathophysiology of psoriasis. , 2006, Journal of the American Academy of Dermatology.

[19]  M. Wei,et al.  [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma]. , 2005, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[20]  K. Robertson.  DNA methylation and human disease , 2005, Nature Reviews Genetics.

[21]  Q. Liao,et al.  [Expression of PDCD5 in tissues of normal cervix, CIN I-III and cervical cancer]. , 2004, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[22]  朱铁君,et al.  Study on the Expression of Apoptosis-Related Molecule PDCD5 in the Skin Lesions of Psoriasis , 2004 .

[23]  B. Haye,et al.  TIMPs as multifacial proteins. , 2004, Critical reviews in oncology/hematology.

[24]  Manel Esteller,et al.  DNA methylation: a profile of methods and applications. , 2002, BioTechniques.

[25]  E. Christophers.  Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.

[26]  N. Tsankov,et al.  Drug-Induced Psoriasis , 2000 .

[27]  F. Weissman,et al.  Pathophysiology and treatment of psoriasis. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[28]  J. Garioch,et al.  Induction of cutaneous lymphocyte-associated antigen expression by group A streptococcal antigens in psoriasis , 1997, Archives of Dermatological Research.

[29]  K. Iwata,et al.  Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.

[30]  A. Eisen,et al.  Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. , 1991, The Journal of investigative dermatology.

[31]  A. Jain,et al.  CURRENT CONCEPTS IN THE PATHOGENESIS OF PSORIASIS , 2009, Indian journal of dermatology.

[32]  G. Krueger,et al.  Epidemiology of psoriasis: clinical issues. , 1994, The Journal of investigative dermatology.